Novonesis outlines Household Care growth strategy
The presentation highlights innovation leadership, regional application excellence, and accelerating biosolutions market.
See the latest news and media coverage for Novonesis. We track all announcements, press releases, and industry mentions in real time, all in one place.
Global biosolutions company
novonesis.comLast updated
In short: Novonesis achieved 7% organic sales growth in 2025 and Q1 2026, while expanding its global manufacturing footprint and biosolutions portfolio.
The presentation highlights innovation leadership, regional application excellence, and accelerating biosolutions market.
The MoU aims to improve ethanol yields and support the country's E10 rollout, strengthening energy security.
CEO Ester Baiget discussed increasing global demand for biosolutions, higher yields, efficiency, and bioenergy in a CNBC interview.
Adjusted EBITDA margin is 37.8%. Confirms 2026 outlook of 5-7% organic sales growth and 37-38% EBITDA margin.
UndoAge and Novonesis, a global biosolutions company backed by Novo Holdings, signed a Memorandum of Understanding (MOU) in ...
Novonesis A/S – Adr (($NVZMY)) has held its Q1 earnings call. Read on for the main highlights of the call. Novonesis A/S opened 2026 on...
Novozymes (CPSE:NSIS B) has drawn investor attention after recent share price moves, with the stock...
COPENHAGEN, Denmark - May 5, 2026. In the first quarter of 2026, Novonesis delivered strong organic sales growth of 7% and an adjusted EBITDA...
Track Novonesis and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.